Long-term survival after surgical resection of locoregional gastric adenocarcinoma recurrence — a case report
Abstract
Introduction. Recurrence is the leading cause of death of gastric cancer patients after curative resection. This report describes a 44-year-old woman with gastric adenocarcinoma and surgically resected locoregional recurrence, who has survived for more than 13 years after diagnosis.
Case report. A 33-year-old woman was admitted to the Gastroenterology Clinic with an episode of epigastric pain and minor weight loss. Two years earlier she had been diagnosed with gastric adenocarcinoma G2 of the antrum, pT2N1M0 (IIA) stage. She had undergone total gastrectomy with D2 lymphadenectomy and Roux-en-Y anastomosis followed by postoperative chemotherapy. Further diagnostic investigation after two years revealed the presence of metastatic cancer in the gastric bed. An explorative laparotomy was performed, and the surgeons successfully excised the enlarged lymph node. Post-operative pathologic examination proved gastric cancer metastasis. Since April 2007 the patient has stayed recurrence-free, and there have been no signs of recurrence on either US or CT scan, as of April 2018. This patient represents a rare case of long-term survival of recurrent gastric adenocarcinoma successfully treated with surgery despite particularly poor prognosis.
Conclusions. Surgery for gastric cancer recurrence is a valuable treatment in chosen patients, provided it is performed by a team of specialised surgeons.
Keywords: gastric carcinomalocoregional recurrencesurgical resection
References
- In H, Ravetch E, Langdon-Embry M, et al. The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging. Gastric Cancer. 2018; 21(1): 1–9.
- Kong F, Qi Y, Liu H, et al. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis. Clin Transl Oncol. 2015; 17(11): 917–924.
- Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005; 241(1): 27–39.
- Lehnert T, Rudek B, Buhl K, et al. Surgical therapy for loco-regional recurrence and distant metastasis of gastric cancer. Eur J Surg Oncol. 2002; 28(4): 455–461.
- Watanabe M, Suzuki H, Maejima K, et al. Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed. Med Sci Monit, 2012;18(7):CS53-56. DOI: 10 1016/j ijscr. 2014; 10: 005.
- de Liaño AD, Yarnoz C, Aguilar R, et al. Surgical treatment of recurrent gastric cancer. Gastric Cancer. 2008; 11(1): 10–14.
- Smyth EC, Verheij M, Allum W, et al. ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016; 27(suppl 5): v38–v49.
- Nunobe S, Hiki N, Ohyama S, et al. Outcome of surgical treatment for patients with locoregional recurrence of gastric cancer. Langenbecks Arch Surg. 2011; 396(2): 161–166.
- Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000; 87(2): 236–242.
- Song KY, Park SM, Kim SN, et al. The role of surgery in the treatment of recurrent gastric cancer. Am J Surg. 2008; 196(1): 19–22.
- Kiyasu Y. Long-term recurrence-free survival after metachronous surgery of the stomach and liver for gastric adenocarcinoma and multiple, synchronous liver metastases: a case report and review of literature. Int Surg. 2013; 98(3): 241–246.
- Ambiru S, Miyazaki M, Ito H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001; 181(3): 279–283.